KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Depreciation and Depletion: 2010-2025

Historic Depreciation and Depletion for Emergent BioSolutions (EBS) over the last 6 years, with Sep 2025 value amounting to $7.1 million.

  • Emergent BioSolutions' Depreciation and Depletion fell 29.70% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.2 million, marking a year-over-year decrease of 29.96%. This contributed to the annual value of $43.7 million for FY2024, which is 26.55% down from last year.
  • According to the latest figures from Q3 2025, Emergent BioSolutions' Depreciation and Depletion is $7.1 million, which was down 2.74% from $7.3 million recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Depreciation and Depletion registered a high of $28.5 million during Q2 2022, and its lowest value of $7.1 million during Q3 2025.
  • Its 3-year average for Depreciation and Depletion is $11.5 million, with a median of $11.7 million in 2024.
  • As far as peak fluctuations go, Emergent BioSolutions' Depreciation and Depletion skyrocketed by 54.05% in 2022, and later plummeted by 42.36% in 2023.
  • Emergent BioSolutions' Depreciation and Depletion (Quarterly) stood at $15.7 million in 2021, then increased by 14.65% to $18.0 million in 2022, then declined by 25.56% to $13.4 million in 2023, then dropped by 27.61% to $9.7 million in 2024, then dropped by 29.70% to $7.1 million in 2025.
  • Its Depreciation and Depletion was $7.1 million in Q3 2025, compared to $7.3 million in Q2 2025 and $9.1 million in Q1 2025.